Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

September 01, 2010; Volume 78,Issue 3

Articles

  • You have access
    Bryostatin 1 Inhibits Phorbol Ester-Induced Apoptosis in Prostate Cancer Cells by Differentially Modulating Protein Kinase C (PKC) δ Translocation and Preventing PKCδ-Mediated Release of Tumor Necrosis Factor-α
    Vivian A. von Burstin, Liqing Xiao and Marcelo G. Kazanietz
    Molecular Pharmacology September 2010, 78 (3) 325-332; DOI: https://doi.org/10.1124/mol.110.064741
  • You have access
    The Role of the Methionines and Histidines in the Transmembrane Domain of Mammalian Copper Transporter 1 in the Cellular Accumulation of Cisplatin
    Christopher A. Larson, Preston L. Adams, Brian G. Blair, Roohangiz Safaei and Stephen B. Howell
    Molecular Pharmacology September 2010, 78 (3) 333-339; DOI: https://doi.org/10.1124/mol.110.064766
  • You have access
    Equilibrium between Adenylyl Cyclase and Phosphodiesterase Patterns Adrenergic Agonist Dose-Dependent Spatiotemporal cAMP/Protein Kinase A Activities in Cardiomyocytes
    Vania De Arcangelis, Shubai Liu, Dawen Zhang, Dagoberto Soto and Yang K. Xiang
    Molecular Pharmacology September 2010, 78 (3) 340-349; DOI: https://doi.org/10.1124/mol.110.064444
  • You have access
    Genome-wide Expression Profiling Revealed Peripheral Effects of Cannabinoid Receptor 1 Inverse Agonists in Improving Insulin Sensitivity and Metabolic Parameters
    Wenqing Zhao, Olivia Fong, Eric S. Muise, John R. Thompson, Drew Weingarth, Su Qian and Tung M. Fong
    Molecular Pharmacology September 2010, 78 (3) 350-359; DOI: https://doi.org/10.1124/mol.110.064980
  • You have access
    Allosteric Inhibition of the Regulator of G Protein Signaling–Gα Protein–Protein Interaction by CCG-4986
    David L. Roman, Levi L. Blazer, C. Aaron Monroy and Richard R. Neubig
    Molecular Pharmacology September 2010, 78 (3) 360-365; DOI: https://doi.org/10.1124/mol.109.063388
  • You have access
    Molecular Determinants for Competitive Inhibition of α4β2 Nicotinic Acetylcholine Receptors
    Patricio Iturriaga-Vásquez, Annalisa Carbone, Olimpo García-Beltrán, Phil D. Livingstone, Philip C. Biggin, Bruce K. Cassels, Susan Wonnacott, Gerald Zapata-Torres and Isabel Bermudez
    Molecular Pharmacology September 2010, 78 (3) 366-375; DOI: https://doi.org/10.1124/mol.110.065490
  • You have access
    Constitutive Androstane Receptor-Mediated Up-Regulation of ATP-Driven Xenobiotic Efflux Transporters at the Blood-Brain Barrier
    Xueqian Wang, Destiny B. Sykes and David S. Miller
    Molecular Pharmacology September 2010, 78 (3) 376-383; DOI: https://doi.org/10.1124/mol.110.063685
  • You have access
    Inhibition of Histone Deacetylase 3 Produces Mitotic Defects Independent of Alterations in Histone H3 Lysine 9 Acetylation and Methylation
    Robyn Warrener, KeeMing Chia, William D. Warren, Kelly Brooks and Brian Gabrielli
    Molecular Pharmacology September 2010, 78 (3) 384-393; DOI: https://doi.org/10.1124/mol.109.062976
  • You have access
    Evidence that Interaction between Conserved Residues in Transmembrane Helices 2, 3, and 7 Are Crucial for Human VPAC1 Receptor Activation
    Anton O. Chugunov, John Simms, David R. Poyner, Yves Dehouck, Marianne Rooman, Dimitri Gilis and Ingrid Langer
    Molecular Pharmacology September 2010, 78 (3) 394-401; DOI: https://doi.org/10.1124/mol.110.063578
  • You have access
    Novel Cationic Lipids with Enhanced Gene Delivery and Antimicrobial Activity
    David E. Fein, Robert Bucki, Fitzroy Byfield, Katarzyna Leszczynska, Paul A. Janmey and Scott L. Diamond
    Molecular Pharmacology September 2010, 78 (3) 402-410; DOI: https://doi.org/10.1124/mol.110.066670
  • You have access
    A Chemical Corrector Modifies the Channel Function of F508del-CFTR
    Patrick Kim Chiaw, Leigh Wellhauser, Ling Jun Huan, Mohabir Ramjeesingh and Christine E. Bear
    Molecular Pharmacology September 2010, 78 (3) 411-418; DOI: https://doi.org/10.1124/mol.110.065862
  • You have access
    Cellular and Pharmacological Selectivity of the Peroxisome Proliferator-Activated Receptor-β/δ Antagonist GSK3787
    Prajakta S. Palkar, Michael G. Borland, Simone Naruhn, Christina H. Ferry, Christina Lee, Ugir H. Sk, Arun K. Sharma, Shantu Amin, Iain A. Murray, Cherie R. Anderson, Gary H. Perdew, Frank J. Gonzalez, Rolf Müller and Jeffrey M. Peters
    Molecular Pharmacology September 2010, 78 (3) 419-430; DOI: https://doi.org/10.1124/mol.110.065508
  • You have access
    Arg13 of B-Type Natriuretic Peptide Reciprocally Modulates Binding to Guanylyl Cyclase but Not Clearance Receptors
    Deborah M. Dickey, Kathryn A. Barbieri, Christopher M. McGuirk and Lincoln R. Potter
    Molecular Pharmacology September 2010, 78 (3) 431-435; DOI: https://doi.org/10.1124/mol.110.066084
  • You have access
    The Histone Deacetylase Inhibitor MGCD0103 Has Both Deacetylase and Microtubule Inhibitory Activity
    KeeMing Chia, Heather Beamish, Kaneez Jafferi and Brian Gabrielli
    Molecular Pharmacology September 2010, 78 (3) 436-443; DOI: https://doi.org/10.1124/mol.110.065169
  • You have access
    Delineating the Mode of Action of Adenosine A1 Receptor Allosteric Modulators
    Celine Valant, Luigi Aurelio, Vijay B. Urmaliya, Paul White, Peter J. Scammells, Patrick M. Sexton and Arthur Christopoulos
    Molecular Pharmacology September 2010, 78 (3) 444-455; DOI: https://doi.org/10.1124/mol.110.064568
  • You have access
    Allosteric Ligands of the Glucagon-Like Peptide 1 Receptor (GLP-1R) Differentially Modulate Endogenous and Exogenous Peptide Responses in a Pathway-Selective Manner: Implications for Drug Screening
    Cassandra Koole, Denise Wootten, John Simms, Celine Valant, Rohan Sridhar, Owen L. Woodman, Laurence J. Miller, Roger J. Summers, Arthur Christopoulos and Patrick M. Sexton
    Molecular Pharmacology September 2010, 78 (3) 456-465; DOI: https://doi.org/10.1124/mol.110.065664
  • You have access
    Resveratrol Protects Dopamine Neurons Against Lipopolysaccharide-Induced Neurotoxicity through Its Anti-Inflammatory Actions
    Feng Zhang, Jing-Shan Shi, Hui Zhou, Belinda Wilson, Jau-Shyong Hong and Hui-Ming Gao
    Molecular Pharmacology September 2010, 78 (3) 466-477; DOI: https://doi.org/10.1124/mol.110.064535
  • You have access
    Protein Kinase C-η and Phospholipase D2 Pathway Regulates Foam Cell Formation via Regulator of G Protein Signaling 2
    Hyung-Kyoung Lee, Seungeun Yeo, Jin-Sik Kim, Jin-Gu Lee, Yoe-Sik Bae, Chuhee Lee and Suk-Hwan Baek
    Molecular Pharmacology September 2010, 78 (3) 478-485; DOI: https://doi.org/10.1124/mol.110.064394
  • You have access
    Antipsychotic Drugs Regulate Hedgehog Signaling by Modulation of 7-Dehydrocholesterol Reductase Levels
    Matthias Lauth, Verena Rohnalter, Åsa Bergström, Mahsa Kooshesh, Per Svenningsson and Rune Toftgård
    Molecular Pharmacology September 2010, 78 (3) 486-496; DOI: https://doi.org/10.1124/mol.110.066431
  • You have access
    Efficient Hypoxic Activation of the Anticancer Agent AQ4N by CYP2S1 and CYP2W1
    Clinton R. Nishida, Melody Lee and Paul R. Ortiz de Montellano
    Molecular Pharmacology September 2010, 78 (3) 497-502; DOI: https://doi.org/10.1124/mol.110.065045
  • You have access
    Regulation of Mouse Brain-Selective Sulfotransferase Sult4a1 by cAMP Response Element-Binding Protein and Activating Transcription Factor-2
    Neville J. Butcher, Deanne J. Mitchell, Rachel Burow and Rodney F. Minchin
    Molecular Pharmacology September 2010, 78 (3) 503-510; DOI: https://doi.org/10.1124/mol.110.063404
  • You have access
    The Effect of Allosteric Modulators on the Kinetics of Agonist-G Protein-Coupled Receptor Interactions in Single Living Cells
    Lauren T. May, Tim J. Self, Stephen J. Briddon and Stephen J. Hill
    Molecular Pharmacology September 2010, 78 (3) 511-523; DOI: https://doi.org/10.1124/mol.110.064493
  • You have access
    Reversible, Allosteric Small-Molecule Inhibitors of Regulator of G Protein Signaling Proteins
    Levi L. Blazer, David L. Roman, Alfred Chung, Martha J. Larsen, Benjamin M. Greedy, Stephen M. Husbands and Richard R. Neubig
    Molecular Pharmacology September 2010, 78 (3) 524-533; DOI: https://doi.org/10.1124/mol.110.065128
Back to top
PreviousNext

In this issue

Molecular Pharmacology: 78 (3)
Molecular Pharmacology
Vol. 78, Issue 3
1 Sep 2010
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Articles
  • Most Read
Loading
  • How Many G Protein-Coupled Receptors are Drug Targets?
  • Histamine H3 Receptor
  • Peptide Nanoformulations against the Tumor Microenvironment
  • Characterization of Vixotrigine
  • Dehydrocrenatidine Is a Novel JAK Inhibitor
More...
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics